SCHEMBL9503300

SCHEMBL9503300

CCCCCCCCCCCCCC[N+](C)(C)C.COC(=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 6/20 0.60
APAF1 O14727 1/20 0.56
HSP90AA1 P07900 1/20 0.56
RAD52 P43351 1/20 0.56
LSS P48449 1/20 0.45
ACHE P22303 3/20 0.44
MEN1 O00255 2/20 0.44
NFKB1 P19838 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
APEX1 P27695 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44
PMP22 Q01453 1/20 0.44
ESR1 P03372 1/20 0.43
ADORA3 P0DMS8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31164000 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL28701370 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL31164024 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL31164020 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL31164014 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL31164019 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL5157900 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL5161951 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL17199725 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS
SCHEMBL28170527 1.00 DNM1 (0.60) DNM1APAF1HSP90AA1RAD52LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2937369-B1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT, AND USE FOR SAID CATALYST TOSOH CORP (JP) 2020-11-11 EP claimed
US-20150344727-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT AND USE THEREOF TOSOH CORPORATION (JP) 2015-12-03 US claimed
EP-2937369-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT, AND USE FOR SAID CATALYST Tosoh Corporation (JP) 2015-10-28 EP claimed
EP-4692150-A1 CURABLE COMPOSITION AND CURED PRODUCT OF SAME DIC Corporation (JP) 2026-02-11 EP disclosed
WO-2024209935-A1 CURABLE COMPOSITION AND CURED PRODUCT OF SAME DIC株式会社 2024-10-10 WO disclosed
EP-2937369-B1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT, AND USE FOR SAID CATALYST TOSOH CORP (JP) 2020-11-11 EP disclosed
CN-109320420-A A kind of synthetic method of chain alkyl methyl carbonate quaternary ammonium salt 厦门医学院 2019-02-12 CN disclosed
US-20150344727-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT AND USE THEREOF TOSOH CORPORATION (JP) 2015-12-03 US disclosed
EP-2937369-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT, AND USE FOR SAID CATALYST Tosoh Corporation (JP) 2015-10-28 EP disclosed
EP-0345475-B1 PROCESS FOR THE PRODUCTION OF QUATERNARY AMMONIUM SALTS OF LONG-CHAIN ALIPHATIC CARBOXYLIC ACIDS HOECHST AKTIENGESELLSCHAFT (DE) 1993-04-21 EP disclosed
EP-0345475-A1 Process for the production of quaternary ammonium salts of long-chain aliphatic carboxylic acids HOECHST AKTIENGESELLSCHAFT (DE) 1989-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344727-A1 QUATERNARY AMMONIUM SALT-CONTAINING CATALYST FOR DISSOCIATION OF BLOCKING AGENT AND USE THEREOF CA2, KCNMB1, BET1 DNM1 780/4885APAF1 2421/4885HSP90AA1 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.